Funding for this research was provided by:
Science and Technology Commission of Shanghai Municipality (16411965500 ; 16511102802)
Received: 4 October 2018
Accepted: 14 March 2019
First Online: 2 May 2019
Ethics approval and consent to participate
: The Ethics Commission of Tongji-University affiliated Tongji-Hospital approved the study on 16th of March 2016 (Reference Number: 伦审-KYSB-2016-74). This approval is applicable for all participating centers (Tongji-Hospital, Yangpu-Hospital, Tenth-Hospital and 455 Hospital). All patients with suspected AMI were asked for their permission to be interviewed and had to give written consent. Study participation was voluntary, patients were informed about the procedures of the study and they were assured that refusal would not affect their treatment. When written consent was not possible due to somatic weakness (e.g. poor eyesight), oral consent had to be given and was documented.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.